Search Results 691-700 of 17069 for monoclonal antibody
PHOENIX — Mayo Clinic researchers are studying a new class of immunotherapy drugs called "bispecific antibodies" that have demonstrated potent tumor-killing ...
A Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) as Monotherapy or in Combination With Avastin (Bevacizumab) Compared to Sunitinib in Patients ...
antibody (TDB) antibody including non BCMA targeting TDB - Prior use of any monoclonal antibody (mAb), radioimmunoconjugate, or ADC as anti-cancer therapy ...
Monoclonal antibodies, such as nivolumab, may interfere with the ability of cancer cells to grow and spread. Midostaurin may stop the growth of cancer cells ...
It significantly negated the value of some of our monoclonal antibodies. So ... So, the theory had been that these allergic reactions are mediated by an antibody ...
... antibody targeted therapy due to mesenchymal epithelial transition factor (MET) amplification. ... monoclonal antibody therapy (panitumumab or cetuximab) ...
* Any previous treatment with anti-CD19 antibody, complement inhibitors, neonatal Fc receptor antagonists, anti-B-lymphocyte stimulator monoclonal antibody * ...
“BEXXAR is an intravenous monoclonal antibody that's directed against the proteins located ... Monoclonal antibodies identify the bad cancer cells and ...
Impact of anti-amyloid-β monoclonal antibodies on the pathology and clinical profile of Alzheimer's disease: A focus on aducanumab and lecanemab. Frontiers ...
About this study. The purpose of this research is to validate new testing methods for diagnosing patients with Treponema pallidum (syphilis).
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.